Sentences with phrase «year duration of the program»

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

A large component of the project comprised of a breastfeeding peer support program which consisted of prenatal visits, hospital visits, home visits and phone calls with anticipatory breastfeeding guidance for up to an infants» first year of life to ascertain that woman in the study will breastfeed for longer durations to establish a link between DHA and neurological development.

Twenty - nine percent of children 2 to 3 years of age have a television in their bedroom, and 30 % of parents have reported that watching a television program enabled their children to fall asleep.3 Although parents perceive a televised program to be a calming sleep aid, some programs actually increase bedtime resistance, delay the onset of sleep, cause anxiety about falling asleep, and shorten sleep duration.41 Specifically, in children younger than 3 years, television viewing is associated with irregular sleep schedules.42 Poor sleep habits have adverse effects on mood, behavior, and learning.

Integrated Management of Childhood Illness (IMCI)- Part III - Chapter 11 - Breastfeeding Nutrient adequacy of exclusive breastfeeding for the term infant during the first six months of life (2002) Geneva, World Health Organization Full text [pdf 278kb] The optimal duration of exclusive breastfeeding: a systematic review Geneva, World Health Organization, 2001 Full text [pdf 1.06 Mb] Report of the expert consultation of the optimal duration of exclusive breastfeeding Report of an expert consultation Geneva, World Health Organization, 28 - 30 March 2001 Full text [pdf 122kb] The WHO Global Data Bank on Infant and Young Child Feeding Breastfeeding and Complementary Feeding Feeding Your Baby From Six Months To One Year Your guide to help you introduce food to your baby Adapted and reproduced with permission of Peel Public Health, Region of Peel A Practical Workbook to Protect, Promote and Support Breastfeeding in Community Based Projects Health Canada, Ottawa, 2002 This workbook is intended to assist the Canada Prenatal Nutrition Program (CPNP) or similar community based prenatal projects to identify strategies and specific actions to protect, promote and support breastfeeding in a population health context.

Under the reforms, CIHR essentially obliterated its array of existing grant programs, replacing them with a regime that essentially awards two types of grants: «Foundation scheme» grants that provided $ 38,800 to $ 1.16 million annually for up to 7 years for work on more open - ended research (with duration and size pegged to how «established» a researcher was); and «Project scheme» grants of $ 38,800 to $ 581,000 annually for up to 5 years for more focused research projects.

Encouraging — but not requiring — NIH institutes and programs to support doctoral study for a maximum duration of 5 years, with extra time permitted in special circumstances

These programs provide opportunities for visiting professionals from industry or universities to participate in established research studies at Ames Laboratory, usually for periods of six months to one year in duration.

After many years of treating psoriasis patients in my clinic, I have not been convinced that all patients need to strictly avoid all fruits with candida issues, but do request that those with chronic psoriasis of several years duration follow my eating program as outlined in The Psoriasis Diet book.

For example, additional evaluation of the NYC Leadership Academy's Aspiring Principals Program noted a limited impact on student achievement in ELA (particularly after the second year of the program), but no effect on student achievement in math — regardless of the duration of the intervProgram noted a limited impact on student achievement in ELA (particularly after the second year of the program), but no effect on student achievement in math — regardless of the duration of the intervprogram), but no effect on student achievement in math — regardless of the duration of the intervention.

24 - Hour Emergency Roadside Assistance: Mazda Certified Pre-Owned buyers and qualified family members are covered 24/7 with the complimentary Mazda 24 - Hour Emergency Roadside Assistance Program for the duration of the 7 - Year / 100, 000 - Mile Limited Powertrain Warranty in the U.S. and Canada.

Details: Program known as Certified Pre-owned; 130 - point inspection; balance of new car warranty, up to six years / 160, 000 km; Volvo On Call coverage for duration of warranty period; up to $ 1,000 in reimbursement of trip cancellation expenses.

The program offers a 12 - month / 12, 000 - mile limited vehicle warranty, 7 - year / 100, 000 - mile limited powertrain warranty, and zero deductible on covered repairs, plus 24 - hour roadside assistance across the United States for the duration of the powertrain warranty.

We believe that the waiting period should be variable based on the duration of a program, with a maximum period of five years.

Your child could receive a CESG of up to $ 500 11 a year, up to a maximum of $ 7,200 for the duration of the program, until the calendar year in which he or she turns 17.

At the time a servicer provides the written notice pursuant to § 1024.41 (c)(2)(iii), if the servicer lacks information necessary to determine the amount of a specific payment due during the program or plan (for example, because the borrower's interest rate will change to an unknown rate based on an index or because an escrow account computation year as defined in § 1024.17 (b) will end and the borrower's escrow payment might change), the servicer complies with the requirement to disclose the specific payment terms and duration of a short - term payment forbearance program or short - term repayment plan if the disclosures are based on the best information reasonably available to the servicer at the time the notice is provided and the written notice identifies which payment amounts may change, states that such payment amounts are estimates, and states the general reason that such payment amounts might change.

SoFi's average lifetime savings methodology for its Employer Contribution Program excludes: 1) enrollees from employers that do not apply the contribution for the duration of the enrollee's loan; 2) enrollees with loan terms of 25 years or greater who have a remaining loan balance under $ 60,000; and 3) enrollees with loan terms greater than 30 years.

Credit card companies DO have hardship programs (although none of my 13 creditors offered such a program, nor were they known to me at the time), but they typically have a duration of one year, which typically is not enough time for a person heavily in debt to pay off the money they owe.

A board - certified veterinary behaviorist (Diplomate of the American College of Veterinary Behaviorists) has completed an approved Residency or Specialty Training Program (three to five years in duration) in the field of Veterinary Behavior Medicine, has published a peer - reviewed paper, submitted and passed three case reports and passed the two - day certifying board examination.

The Reading Program will run on Tuesdays from 5 p.m. to 6 p.m. for the duration of the 2017/2018 school year.

Secondly, a board certified veterinary behaviorist (Diplomate of the American College of Veterinary Behaviorists) has completed an approved Residency or Specialty Training Program (3 - 5 years in duration) in the field of Veterinary Behavior has published a peer reviewed paper, submitted and passed 3 case reports and passed the two day certifying board examination.

a) Institutional — Open to those schools, colleges, universities, and organizations which are accredited by national or regional educational accrediting bodies and which offer professional veterinary technician educational programs at the post-secondary level which are of two academic years or equivalent in duration or greater.

Gap year volunteer programs are amazing travel experiences, where you will be expected to work hard for the duration of your placement.

Members of the Global Entry program may use Global Entry kiosks at any participating airport for a duration of five years.

residency program for 10 - year duration, the first of its kind in campus history.

As of December 15th, 2011, people who are under the live - in caregiver program who have submitted an application for permanent residence under such class AND have also submitted an application for an open work permit will be issued an open work permit for a duration of up to four (4) years as long as their -LSB-...]

The duration of these programs is 4 years and is designed for graduating college seniors in diverse disciplines, who aim to be a significant part of the global business milieu.

Most education programs award a pharmacy technician certificate after one year or less, but some require further training or a longer duration of schooling.

Participation in their programs can be for the full duration of their homelessness or the school year.

Nurse - based home - visiting programs tend to have better staff retention compared with those that employ paraprofessionals, perhaps contributing to program effectiveness.26, 27 Likewise, programs in which paraprofessionals remained involved over a 2 - year time period were more likely to demonstrate effectiveness than those with shorter durations of involvement.28

Scoring programs for the CAPA and YAPA, written in SAS, 41 combined information about the date of onset, duration, and intensity of each symptom to create diagnoses according to the DSM - IV.29 With the exception of attention - deficit / hyperactivity disorder (ADHD), for which only parental reports were counted, a symptom was counted as present if it was reported by either the parent or the child until age 16 years or by the young adult at ages 19 and 21 years, as is standard clinical practice.

The efficacy of a community - run Parents Plus Early Years Program as a preschool parenting intervention of modifiable duration.

Depending on the age of the participant when s / he enters the program, duration could be anywhere from 6 months to five or more years.

NHSA's formal comments, supported by every state and regional association and hundreds of programs and individuals, proposed that extended duration call for 1,020 hours of services per year rather than a particular numbers of hours and days in order for programs to have the flexibility to meet local needs.

Early engagement was studied in three ways: (1) length of time active in the program during the first year of service (duration), (2) number of visits received (quantity), and (3) gaps in service between visits (consistency).